These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18039197)

  • 1. Treatment of the spasticity in children with cerebral palsy.
    Meholjić-Fetahović A
    Bosn J Basic Med Sci; 2007 Nov; 7(4):363-7. PubMed ID: 18039197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K; Forsberg A
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles.
    Kaya Keles CS; Ates F
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin type A treatment in children with spasticity.
    Sarioglu B; Serdaroglu G; Tutuncuoglu S; Ozer EA
    Pediatr Neurol; 2003 Oct; 29(4):299-301. PubMed ID: 14643391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the motor cerebral palsy child with botulinum toxin A: mode of action, injection places in management].
    Carrelet P; Bollini G; Mancini J; Chabrol B
    Arch Pediatr; 2002 Sep; 9(9):928-33. PubMed ID: 12387176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy.
    Picelli A; La Marchina E; Gajofatto F; Pontillo A; Vangelista A; Filippini R; Baricich A; Cisari C; Smania N
    Dev Neurorehabil; 2017 Apr; 20(3):160-164. PubMed ID: 26890193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U; Bastiaenen C; De Bie R; Staal B
    Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
    Meholjic A; Madjar D
    Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.